As of 2026-04-13, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 0.32 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 7.65 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -95.9%.
The range of the Relative Valuation is (0.10) - 1.83 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.8x - 7.1x | 2.9x |
| Forward P/E multiples | 11.8x - 42.8x | 18.5x |
| Fair Price | (0.10) - 1.83 | 0.32 |
| Upside | -101.3% - -76.0% | -95.9% |
| Date | P/E |
| 2026-04-10 | -137.72 |
| 2026-04-09 | -139.55 |
| 2026-04-08 | -137.36 |
| 2026-04-07 | -139.55 |
| 2026-04-06 | -140.28 |
| 2026-04-02 | -135.90 |
| 2026-04-01 | -135.72 |
| 2026-03-31 | -135.17 |
| 2026-03-30 | -133.16 |
| 2026-03-27 | -131.34 |
| 2026-03-26 | -129.15 |
| 2026-03-25 | -129.70 |
| 2026-03-24 | -124.22 |
| 2026-03-23 | -124.41 |
| 2026-03-20 | -116.93 |
| 2026-03-19 | -114.92 |
| 2026-03-18 | -112.55 |
| 2026-03-17 | -112.19 |
| 2026-03-16 | -112.00 |
| 2026-03-13 | -111.27 |
| 2026-03-12 | -111.27 |
| 2026-03-11 | -112.92 |
| 2026-03-10 | -114.37 |
| 2026-03-09 | -113.10 |
| 2026-03-06 | -112.37 |
| 2026-03-05 | -113.46 |
| 2026-03-04 | -114.74 |
| 2026-03-03 | -113.64 |
| 2026-03-02 | -115.65 |
| 2026-02-27 | -114.56 |
| 2026-02-26 | -116.20 |
| 2026-02-25 | -114.92 |
| 2026-02-24 | -116.38 |
| 2026-02-23 | -119.66 |
| 2026-02-20 | -117.48 |
| 2026-02-19 | -118.39 |
| 2026-02-18 | -119.48 |
| 2026-02-17 | -116.75 |
| 2026-02-13 | -115.29 |
| 2026-02-12 | -108.90 |
| 2026-02-11 | -107.63 |
| 2026-02-10 | -107.08 |
| 2026-02-09 | -108.54 |
| 2026-02-06 | -107.26 |
| 2026-02-05 | -106.53 |
| 2026-02-04 | -107.44 |
| 2026-02-03 | -107.99 |
| 2026-02-02 | -107.81 |
| 2026-01-30 | -105.80 |
| 2026-01-29 | -105.80 |